Description

6-Chloro-4-Methyl-n-(3-Morpholinopropyl)Benzo[D]Thiazol-2-Amine is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant commercial value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular scaffolds. It is primarily sought after by research institutions and manufacturers in the pharmaceutical and biotechnology sectors engaged in drug discovery and development programs.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of potential drug candidates, especially those targeting central nervous system (CNS) disorders, oncology, and anti-infective therapies.
• Organic Synthesis Building Block: Used in medicinal chemistry for structure-activity relationship (SAR) studies and the development of new chemical entities (NCEs) due to its benzo[d]thiazole core and functionalized side chain.
• Biochemical Research: Employed in academic and industrial R&D laboratories as a reagent for probing biological pathways and enzyme interactions.
• Agrochemical Research: Potential application as an intermediate in the development of new crop protection agents and pesticides, leveraging its heterocyclic framework.
• Material Science Precursor: Can be utilized in the synthesis of specialized organic materials, such as ligands for catalysts or components for organic electronics.

Basic Information

Product Name	6-Chloro-4-Methyl-n-(3-Morpholinopropyl)Benzo[D]Thiazol-2-Amine
CAS No.	1350989-11-5
Molecular Formula	C15H20ClN3OS
Molecular Weight	325.85 g/mol
Synonyms	6-Chloro-4-methyl-N-(3-morpholinopropyl)-1,3-benzothiazol-2-amine; 2-Amino-6-chloro-4-methyl-N-(3-morpholinopropyl)benzothiazole; Benzo[D]thiazol-2-amine, 6-chloro-4-methyl-N-(3-morpholinopropyl)-; 1350989-11-5; 6-Chloro-4-methyl-N-(3-morpholin-4-ylpropyl)-1,3-benzothiazol-2-amine
EINECS	Contact for details

Quality Control

Our production of 6-Chloro-4-Methyl-n-(3-Morpholinopropyl)Benzo[D]Thiazol-2-Amine adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity, essential for sensitive pharmaceutical R&D. Each lot undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to confirm identity and purity. Certificates of Analysis (COA) detailing all test results are available upon request, supporting your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to minimize exposure to atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.